MMP-7: The Next Best Serum Biomarker for Biliary Atresia?
Clinicians face numerous challenges when managing infants with biliary atresia (BA), a serious liver condition characterized by obstruction of the extrahepatic bile ducts. First, they must identify infants with biliary atresia quickly, despite having imperfect noninvasive diagnostic tests. Efficient identification is important, because earlier treatment with the Kasai portoenterostomy correlates with the best chances of delaying or even avoiding need for liver transplant. Unfortunately, current diagnostic tests are imperfect and gold-standard testing is highly invasive.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Sanjiv Harpavat Tags: Editorials Source Type: research
More News: Atresia | Bile | Liver | Liver Transplant | Pediatrics | Transplant Surgery | Transplants | Urology & Nephrology